Business Combinations (Tables)

3 Months Ended

Mar. 31, 2015

Supplementary Pro Forma Information For Business Combinations

These unaudited pro-forma results are presented in compliance with the adoption of Accounting Standards Update ("ASU") 2010-29, Business Combinations (Topic 805), Disclosure of Supplementary Pro Forma Information for Business Combinations, and are not necessarily indicative of the actual consolidated results of operations had the acquisitions actually occurred on January 1, 2014 or January 1, 2013 or of future results of operations of the consolidated entities (in thousands, except per share information):

	Three Months Ended March 31,
	2015		2014
Revenues	$	110,598	$	111,206
Net income	$	4,367	$	3,786
Basic net income per share	$	0.13	$	0.11
Diluted net income per share	$	0.13	$	0.11
Shares used in computing basic net income per share		33,675		32,998
Shares used in computing diluted net income per share		34,181		34,132

ForwardThink [Member]

Business Combinations [Abstract]

Allocation of Total Purchase Price Consideration

The Company allocated the total purchase price consideration between tangible assets, identified intangible assets, liabilities, and goodwill as follows (in millions):

Acquired tangible assets	$	4.5
Acquired intangible assets		18.0
Liabilities assumed		(11.9	)
Goodwill		29.5
Total purchase price	$	40.1

BioPharm [Member]

Business Combinations [Abstract]

Allocation of Total Purchase Price Consideration

The Company allocated the total purchase price consideration between tangible assets, identified intangible assets, liabilities, and goodwill as follows (in millions):

Acquired tangible assets	$	3.4
Acquired intangible assets		8.4
Liabilities assumed		(1.2	)
Goodwill		5.7
Total purchase price	$	16.3

Trifecta [Member]

Business Combinations [Abstract]

Allocation of Total Purchase Price Consideration

The Company allocated the total purchase price consideration between tangible assets, identified intangible assets, liabilities, and goodwill as follows (in millions):

Acquired tangible assets	$	1.6
Acquired intangible assets		5.2
Liabilities assumed		(5.7	)
Goodwill		7.1
Total cash purchase price	$	8.2

Zeon [Member]

Business Combinations [Abstract]

Allocation of Total Purchase Price Consideration

The Company has estimated the allocation of the total purchase price consideration between tangible assets, identified intangible assets, liabilities, and goodwill as follows (in millions):

Acquired tangible assets	$	9.9
Acquired intangible assets		12.7
Liabilities assumed		(3.4	)
Goodwill		16.7
Total cash purchase price	$	35.9

Supplementary Pro Forma Information For Business Combinations

The amount of revenue and net income of Zeon in the Company's Condensed Consolidated Statements of Operations (Unaudited) from the acquisition date to March 31, 2015 are as follows (in thousands):

	Acquisition Date to March 31, 2015
Revenues	$	7,201
Net income	$	674